[go: up one dir, main page]

GB201206209D0 - Marker gene based diagnosis, staging and prognosis of prostate caner - Google Patents

Marker gene based diagnosis, staging and prognosis of prostate caner

Info

Publication number
GB201206209D0
GB201206209D0 GB201206209A GB201206209A GB201206209D0 GB 201206209 D0 GB201206209 D0 GB 201206209D0 GB 201206209 A GB201206209 A GB 201206209A GB 201206209 A GB201206209 A GB 201206209A GB 201206209 D0 GB201206209 D0 GB 201206209D0
Authority
GB
United Kingdom
Prior art keywords
staging
prognosis
marker gene
gene based
based diagnosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB201206209A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Katholieke Universiteit Leuven
Original Assignee
Katholieke Universiteit Leuven
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Katholieke Universiteit Leuven filed Critical Katholieke Universiteit Leuven
Priority to GB201206209A priority Critical patent/GB201206209D0/en
Publication of GB201206209D0 publication Critical patent/GB201206209D0/en
Priority to PCT/EP2012/068810 priority patent/WO2013041731A1/fr
Priority to PCT/EP2013/056510 priority patent/WO2013149904A1/fr
Ceased legal-status Critical Current

Links

GB201206209A 2011-09-23 2012-04-06 Marker gene based diagnosis, staging and prognosis of prostate caner Ceased GB201206209D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GB201206209A GB201206209D0 (en) 2012-04-06 2012-04-06 Marker gene based diagnosis, staging and prognosis of prostate caner
PCT/EP2012/068810 WO2013041731A1 (fr) 2011-09-23 2012-09-24 Diagnostic, stadification et pronostic du cancer de la prostate sur la base d'un gène marqueur
PCT/EP2013/056510 WO2013149904A1 (fr) 2012-04-06 2013-03-27 Diagnostic, détermination du stade et pronostic du cancer de la prostate à base d'un gène marqueur

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB201206209A GB201206209D0 (en) 2012-04-06 2012-04-06 Marker gene based diagnosis, staging and prognosis of prostate caner

Publications (1)

Publication Number Publication Date
GB201206209D0 true GB201206209D0 (en) 2012-05-23

Family

ID=46176998

Family Applications (1)

Application Number Title Priority Date Filing Date
GB201206209A Ceased GB201206209D0 (en) 2011-09-23 2012-04-06 Marker gene based diagnosis, staging and prognosis of prostate caner

Country Status (2)

Country Link
GB (1) GB201206209D0 (fr)
WO (2) WO2013041731A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015070045A1 (fr) * 2013-11-08 2015-05-14 Baylor College Of Medicine Nouveaux marqueurs diagnostiques/pronostiques et cible thérapeutique pour le cancer
GB201322034D0 (en) 2013-12-12 2014-01-29 Almac Diagnostics Ltd Prostate cancer classification
WO2015120382A1 (fr) * 2014-02-07 2015-08-13 The Johns Hopkins University Prédiction de réponse à un traitement utilisant des médicaments épigénétiques
US10801072B2 (en) 2014-09-04 2020-10-13 Miodx Method of analysis allowing avoidance of surgery
EP3037545A1 (fr) * 2014-12-23 2016-06-29 The Provost, Fellows, Foundation Scholars, & the other members of Board, of the College of the Holy & Undiv. Trinity of Queen Elizabeth near Dublin Test de méthylation d'ADN pour le cancer de la prostate
AU2016383531B2 (en) * 2015-12-30 2021-02-25 Technische Universität Dresden Method and means for diagnosing tumors
US11795495B1 (en) * 2019-10-02 2023-10-24 FOXO Labs Inc. Machine learned epigenetic status estimator
CN113215260A (zh) * 2021-06-18 2021-08-06 杭州昱鼎生物科技有限公司 一种gstp1，apc和rassf1在制备前列腺癌标志物中的应用及其试剂盒
CN116179694B (zh) * 2022-11-02 2024-11-05 武汉艾米森生命科技有限公司 检测甲基化水平的试剂在制备前列腺癌诊断产品中的应用以及前列腺癌诊断试剂盒
CN116083588B (zh) * 2023-03-09 2023-09-12 嘉兴允英医学检验有限公司 作为前列腺癌标志物的dna甲基化位点组合及其应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4437975A (en) 1977-07-20 1984-03-20 Mobil Oil Corporation Manufacture of lube base stock oil
IE72468B1 (en) 1987-07-31 1997-04-09 Univ Leland Stanford Junior Selective amplification of target polynucleotide sequences
KR0148265B1 (ko) 1988-12-16 1998-10-15 에프.지이.엠 헤르만스 자가-지속 서열 복제 시스템
US6066625A (en) 1998-02-03 2000-05-23 Methylgene, Inc. Optimized antisense oligonucleotides complementary to DNA methyltransferase sequences
US6953783B1 (en) 1998-10-19 2005-10-11 Methylgene, Inc. Modulation of gene expression by combination therapy
WO2004067726A2 (fr) 2003-01-29 2004-08-12 Keck Graduate Institute Reactions isothermes pour amplification d'oligonucleotides
US20090023134A1 (en) * 2004-03-17 2009-01-22 The Johns Hopkins University Neoplasia diagnostic compositions and methods of use
US8268549B2 (en) * 2005-04-15 2012-09-18 University Of Maryland, Baltimore Method and assay for determining methylation of GAL3 promoter for early diagnosis of prostate cancer
WO2007039291A2 (fr) * 2005-10-03 2007-04-12 Epigenomics Ag Methodes, appareil et nomogrammes utilises pour determiner la progression du cancer de la prostate
WO2009089598A2 (fr) * 2008-01-18 2009-07-23 Katholieke Universiteit Leuven Diagnostic à base de gène msmb, stadification et pronostic du cancer de la prostate
AU2009253675A1 (en) * 2008-05-28 2009-12-03 Genomedx Biosciences, Inc. Systems and methods for expression-based discrimination of distinct clinical disease states in prostate cancer

Also Published As

Publication number Publication date
WO2013149904A1 (fr) 2013-10-10
WO2013041731A1 (fr) 2013-03-28

Similar Documents

Publication Publication Date Title
GB201206209D0 (en) Marker gene based diagnosis, staging and prognosis of prostate caner
IL304337A (en) Antiandrogens for the treatment of castration-resistant prostate cancer without metastases
EP2847593A4 (fr) Procédés pour prédire et détecter le risque de cancer
SG10201710447QA (en) Pancreatic cancer biomarkers and uses thereof
PL2576837T3 (pl) Krążeniowe biomarkery typu kwasu nukleinowego związane z rakiem prostaty
EP2867376A4 (fr) Méthodes ciblées connues sous le nom d'arn-seq et matériaux pour le diagnostic du cancer de la prostate
GB201414085D0 (en) Breast cancer diagnosis and indication marker
GB2515414B (en) Data staging area
SG11201500396TA (en) Tumor vaccination
SG11201402115TA (en) Methods for diagnosis and/or prognosis of gynecological cancer
SMT202100545T1 (it) Vaccini contro il cancro mirati alle cellule staminali cancerose
EP2807542A4 (fr) Représentation graphique d'un ordre d'opérations
GB2510539B (en) Biomarkers of cancer
EP2932273A4 (fr) Méthodes de diagnostic et de traitement du cancer de la prostate
GB2498524B (en) Tunnel Lining
GB201209420D0 (en) Prognostic gene
SG11201501838RA (en) Completion assembly and methods for use thereof
GB201107118D0 (en) Method of diagnosis and prognosis
EP2673379A2 (fr) Séquences de marqueurs pour le diagnostic du cancer de la prostate et leur utilisation
GB201206946D0 (en) Diagnostic gene
GB201204314D0 (en) Methods for pipe lining and pipe manufacture
GB201220082D0 (en) Assessment of pancreatic cancer
GB201002366D0 (en) Cancer prognosis
GB201212964D0 (en) Diagnostic and prognostic methods
GB201009217D0 (en) Targeted gene therapy

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)